Christopher M. Starr - Director at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

Christopher M. Starr - trading volume in the past year for Monopar Therapeutics

Holdings reported by Christopher M. Starr for Monopar Therapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 9.88K $334K $33.82 Jul 14, 2025 Indirect
Common Stock 5.17K $207K $40.00 Jul 14, 2025 Direct
Stock Options 0 Jul 14, 2025 Direct Common Stock

Transactions reported by Christopher M. Starr for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.